Skip to main content

Find Clinical Trials

Home
Conditions
Haemophilus Influenzae Type b

Clinical trial condition

Haemophilus Influenzae Type b

Explore clinical trials studying Haemophilus Influenzae Type b. Study availability and eligibility vary by location and protocol.

83 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Haemophilus Influenzae Type b trial results

Completed

A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

NCT00317174

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

NCT01457560

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: Not specified

View Trial Details

Completed

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

NCT01457547

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Helsinki, Finland

GSK Investigational Site Bari, Apulia, Italy

GSK Investigational Site Galatina (LE), Apulia, Italy

GSK Investigational Site Maglie (LE), Apulia, Italy

View Trial Details

Completed

Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and Toddlers

NCT00343421

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +29 more
Locations: Paris, France

Poznan, Poland

View Trial Details

Completed

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants

NCT00831753

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Lima, Peru

View Trial Details

Completed

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

NCT01983540

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +35 more
Locations: Cali, Colombia

San José, Costa Rica

View Trial Details

Completed

Study of Modified Process Hib/Hep B Vaccine in Infants (V121-019)(COMPLETED)

NCT00441012

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +14 more
Locations: Not specified

View Trial Details

Completed

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

NCT00287092

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +29 more
Locations: Espoo, Finland

Helsinki, Finland

Helsinki, Finland

Jarvenpaa, Finland

View all 14 locations

View Trial Details

Completed

Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV

NCT00362336

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +35 more
Locations: Soweto, Johannesburg, South Africa

Bertsham, South Africa

View Trial Details

Completed

Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.

NCT00313911

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Mexico City, Mexico

Lima, Peru

View Trial Details